Abound Wealth Management Novo Cure LTD Transaction History
Abound Wealth Management
- $301 Billion
- Q3 2024
A detailed history of Abound Wealth Management transactions in Novo Cure LTD stock. As of the latest transaction made, Abound Wealth Management holds 54 shares of NVCR stock, worth $941. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54
Previous 54
-0.0%
Holding current value
$941
Previous $926,000
8.75%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
264Shares Held
78.9MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$212 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$204 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$194 Million0.0% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$52.8 Million12.67% of portfolio
-
State Street Corp Boston, MA3.01MShares$52.4 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.83B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...